Berylson Capital Partners’s CM Life Sciences, Inc. Unit CMLFU Stock Holding History

Berylson Capital Partners’s Portfolio CMLFU Stock Details CMLFU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000,000	Closed	-$15.8M	–	69
2021 Q2	$15.8M	Hold	1,000,000	–	–	3.49%	6
2021 Q1	$16.4M	Hold	1,000,000	–	–	4%	5
2020 Q4	$11.6M	Hold	1,000,000	–	–	1.98%	16
2020 Q3	$10.5M	Buy	+1,000,000	New	+$10.5M	3.66%	8

Berylson Capital Partners's CMLFU Position: Q3 2021 in Review

Berylson Capital Partners sold out of CM Life Sciences, Inc. Unit (CMLFU) in Q3 2021, closing a stake of 1,000,000 shares — an estimated $15.8M sold.

Berylson Capital Partners first reported a position in CMLFU in Q3 2020 and held it in 4 quarters. The position peaked at $16.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMLFU as of Q3 2021.

Berylson Capital Partners reported no remaining CM Life Sciences, Inc. Unit position as of Q3 2021 after selling out during the quarter.
Berylson Capital Partners sold 1,000,000 CM Life Sciences, Inc. Unit shares in Q3 2021, an estimated $15.8M.
Berylson Capital Partners first reported a position in CM Life Sciences, Inc. Unit in Q3 2020 and held it in 4 quarters.
Berylson Capital Partners's CM Life Sciences, Inc. Unit position peaked at $16.4M in Q1 2021.
0 funds tracked by Wall St. Rank held CM Life Sciences, Inc. Unit as of Q3 2021.

Based on Berylson Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.